Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | PI103 | 0.1 | uM | IL-17A | 100 | ng/mL | 4 | IFN-a2 | 28.0 | 66 | |
RA2159 | Sigma A6730 | 3.0 | uM | IL-17A | 100 | ng/mL | 4 | IFN-a2 | 23.0 | 65 | |
RA2159 | JNK-IN-8 | 3.0 | uM | IL-17A | 100 | ng/mL | 4 | IFN-a2 | 25.0 | 71 | |
RA2159 | JNK-IN-11 | 0.3 | uM | IL-17A | 100 | ng/mL | 4 | IFN-a2 | 19.0 | 41 | |
RA2159 | Tofacitinib | 0.3 | uM | 4 | IFN-a2 | 24.5 | 28 | ||||
N2586 | IL-17A | 100 | ng/mL | 4 | IFN-a2 | 64.0 | 51 | ||||
N2586 | EO1428 | 1.0 | uM | IL-17A | 100 | ng/mL | 4 | IFN-a2 | 61.0 | 66 | |
N2586 | PI103 | 0.1 | uM | IL-17A | 100 | ng/mL | 4 | IFN-a2 | 68.0 | 52 | |
N2586 | Sigma A6730 | 3.0 | uM | IL-17A | 100 | ng/mL | 4 | IFN-a2 | 56.0 | 52 | |
N2586 | JNK-IN-8 | 3.0 | uM | IL-17A | 100 | ng/mL | 4 | IFN-a2 | 47.0 | 57 | |
N2586 | JNK-IN-11 | 0.3 | uM | IL-17A | 100 | ng/mL | 4 | IFN-a2 | 34.0 | 53 | |
N2586 | Tofacitinib | 0.3 | uM | 4 | IFN-a2 | 28.5 | 52 | ||||
RA2159 | IL-6 | 100 | ug/mL | 4 | IFN-a2 | 29.0 | 53 | ||||
RA2159 | EO1428 | 1.0 | uM | IL-6 | 100 | ug/mL | 4 | IFN-a2 | 25.0 | 59 | |
RA2159 | PI103 | 0.1 | uM | IL-6 | 100 | ug/mL | 4 | IFN-a2 | 22.0 | 59 | |
RA2159 | Sigma A6730 | 3.0 | uM | IL-6 | 100 | ug/mL | 4 | IFN-a2 | 25.0 | 50 | |
RA2159 | JNK-IN-8 | 3.0 | uM | IL-6 | 100 | ug/mL | 4 | IFN-a2 | 21.0 | 49 | |
RA2159 | JNK-IN-11 | 0.3 | uM | IL-6 | 100 | ug/mL | 4 | IFN-a2 | 17.0 | 49 | |
RA2159 | Ruxolitinib | 0.3 | uM | 4 | IFN-a2 | 22.0 | 49 | ||||
N2586 | IL-6 | 100 | ug/mL | 4 | IFN-a2 | 43.0 | 52 | ||||
N2586 | EO1428 | 1.0 | uM | IL-6 | 100 | ug/mL | 4 | IFN-a2 | 54.0 | 55 | |
N2586 | PI103 | 0.1 | uM | IL-6 | 100 | ug/mL | 4 | IFN-a2 | 41.0 | 40 | |
N2586 | Sigma A6730 | 3.0 | uM | IL-6 | 100 | ug/mL | 4 | IFN-a2 | 51.0 | 63 | |
N2586 | JNK-IN-8 | 3.0 | uM | IL-6 | 100 | ug/mL | 4 | IFN-a2 | 39.0 | 53 | |
N2586 | JNK-IN-11 | 0.3 | uM | IL-6 | 100 | ug/mL | 4 | IFN-a2 | 32.0 | 41 |